BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 6242952)

  • 1. A double blind cross-over comparison of piroxicam and indomethacin in the treatment of rheumatoid arthritis.
    Davies J; Dixon AS; Ring EF
    Eur J Rheumatol Inflamm; 1981; 4(3):314-7. PubMed ID: 6242952
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kidney function in therapy with non-steroidal antiphlogistic drugs. A double-blind cross-over study with diclofenac, indomethacin and piroxicam].
    Lang B; Hauk P; Meske S; Keller E; Peter HH
    Z Rheumatol; 1991; 50(6):366-70. PubMed ID: 1796656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind crossover comparison of piroxicam and indomethacin in rheumatoid arthritis.
    Domljan Z; Durrigl T
    Eur J Rheumatol Inflamm; 1983; 6(3):291-6. PubMed ID: 6391934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, crossover, multicentre study of piroxicam and indomethacin in the treatment of rheumatoid arthritis.
    Finstad R
    Br J Clin Pract; 1981 Jan; 35(1):35-9. PubMed ID: 7020731
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of piroxicam with naproxen in rheumatoid arthritis: a double-blind, cross-over, multicentre study.
    Sydnes OA
    Eur J Rheumatol Inflamm; 1981; 4(3):318-22. PubMed ID: 6242953
    [No Abstract]   [Full Text] [Related]  

  • 6. European double-blind multicenter study comparing meclofenamate sodium and indomethacin in the treatment of rheumatoid arthritis.
    Dunky A; Mattern H
    Arzneimittelforschung; 1983; 33(4A):636-40. PubMed ID: 6349647
    [No Abstract]   [Full Text] [Related]  

  • 7. Once-daily piroxicam in rheumatoid arthritis: a double-blind cross-over comparison with aloxiprin.
    Roberts SD; Vir C; Porter KG
    Eur J Rheumatol Inflamm; 1981; 4(3):323-31. PubMed ID: 6086096
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study with indomethacin and combined indomethacin sodium-salicylate in rheumatoid arthritis.
    Torgyán S; Wagner L; Neumann T; Pakuts B; Csányi M
    Int J Clin Pharmacol Biopharm; 1979 Nov; 17(11):439-41. PubMed ID: 389838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind comparison of etodolac and piroxicam in the treatment of rheumatoid arthritis.
    Dick WC; Franchimont P; Veys E
    Clin Ther; 1993; 15(1):148-59. PubMed ID: 8458044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of piroxicam in rheumatoid arthritis by double blind comparative multi-center studies].
    Ryumachi; 1980 Jun; 20(3):220-8. PubMed ID: 6998024
    [No Abstract]   [Full Text] [Related]  

  • 11. Four popular anti-inflammatories. Which?
    Huskisson EC; Greenwood A
    Br J Clin Pract; 1988 Oct; 42(10):415-8. PubMed ID: 3255421
    [No Abstract]   [Full Text] [Related]  

  • 12. [Double-blind parallel clinical trial with tenoxicam in comparison with indomethacin in the treatment of rheumatoid arthritis].
    Honorato J; Cuena R; Azanza JR
    Rev Med Univ Navarra; 1984 Sep; 28(3):49-53. PubMed ID: 6397802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of naproxen and piroxicam in rheumatoid arthritis and Bechterew's syndrome. A double-blind parallel multicenter study].
    Myklebust G
    Tidsskr Nor Laegeforen; 1986 Jun; 106(17-18):1485-7. PubMed ID: 3532419
    [No Abstract]   [Full Text] [Related]  

  • 14. [Piroxicam in the treatment of rheumatoid arthritis].
    Murav'ev IuV; Mamistova AI; Sigidin IaA
    Ter Arkh; 1988; 60(4):128-30. PubMed ID: 3293252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piroxicam vs. aspirin and indomethacin: efficacy, safety, and compliance in osteoarthritis and rheumatoid arthritis.
    Gordon GV
    Postgrad Med; 1983 May; Spec No():18-22. PubMed ID: 6348717
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical trails of piroxicam suppositories in the therapy of rheumatoid arthritis].
    Iwata H; Nakajima M; Nobenaga T
    Ryumachi; 1987 Apr; 27(2):147-55. PubMed ID: 3317919
    [No Abstract]   [Full Text] [Related]  

  • 17. Diclofenac and piroxicam in a double-blind trial results and methodological problems. Working Party of the Society for Rheumatology of the GDR for the Testing of Anti-rheumatic Drugs.
    Keitel W; Friedländer R; Häntzschel H; Hüge W; Keysser M; Seidel W; Tanner E; Wächter G; Weber J; Wille R
    Eur J Rheumatol Inflamm; 1984; 7(3):105-13. PubMed ID: 6400520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of Prolixan 300 (Azapropazone) on the course of rheumatoid disease and degenerative joint disease. Comparison with indomethacin by means of a double blind test].
    Kawenoki-Minc E; Gburek Z; Sadkiewicz S; Keller B; Piotrowska E; Rajpert D; Reszkowska H
    Reumatologia; 1979; 17(3):365-74. PubMed ID: 390661
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of the efficacy, safety, and pharmacokinetic profiles of extended-release ketoprofen and piroxicam in patients with rheumatoid arthritis.
    Caldwell JR
    Clin Ther; 1994; 16(2):222-35. PubMed ID: 8062318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind comparison of piroxicam and indomethacin in the treatment of cervicobrachial syndrome and periarthritis scapulohumeralis (stiff shoulder).
    Yamamoto M; Sugano T; Kashiwazaki S; Kageyama T; Mizushima Y; Kameyama M
    Eur J Rheumatol Inflamm; 1983; 6(3):266-73. PubMed ID: 6391931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.